We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBiome Tech Regulatory News (BIOM)

Share Price Information for Biome Tech (BIOM)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 77.50
Bid: 70.00
Ask: 85.00
Change: 0.00 (0.00%)
Spread: 15.00 (21.429%)
Open: 77.50
High: 77.50
Low: 77.50
Prev. Close: 77.50
BIOM Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Holdings in Company

13 Mar 2019 13:54

RNS Number : 7826S
Biome Technologies PLC
13 March 2019
 

 

13 March 2019

 

Biome Technologies plc

("Biome", "the Company" or "the Group")

 

Holdings in Company

 

 

Biome Technologies plc, a leading bioplastics and radio frequency technology business, announces the following updates regarding certain of the Company's significant shareholders.

 

The Company was informed on 10 March 2019 of certain changes to the interests in ordinary shares of 5 pence each in the Company ("Ordinary Shares") of various members of the Pereira family (the "Pereira Family"), which the Company understands have come about primarily due to transfers of Ordinary Shares between certain Pereira Family members in April 2018. In total the Pereira Family are beneficially interested in a total of 700,841 Ordinary Shares, which is equivalent to 29.63% of the current voting rights in the Company.

 

The Company has been informed that Mr V Pereira has a beneficial interest in 451,606 Ordinary Shares, which is equivalent to 19.09% of the current voting rights in the Company. The Company was also informed that Mr V Pereira's wife, Mrs G Pereira, has a beneficial interest in 82,416 Ordinary Shares, which is equivalent to 3.48% of the current voting rights in the Company.

 

The Company was further informed that Miss G Pereira and Miss B Pereira, being the adult daughters of Mr V Pereira and Mrs G Pereira, have beneficial interests in 79,286 Ordinary Shares and 78,149 Ordinary Shares respectively, which are equivalent to 3.35% and 3.30% of the current voting rights in the Company.

 

The beneficial interest of another member of the Pereira Family is below 3% of the current voting rights in the Company and therefore does not represent a notifiable interest for the purposes of the AIM Rules for Companies and the Disclosure Guidance and Transparency Rules.

 

 

- Ends -

 

 

 

For further information please contact: Biome Technologies plc

 

Paul Mines, Chief Executive Officer

Declan Brown, Group Finance Director

www.biometechnologiesplc.com

Tel: +44 (0) 2380 867 100

 

Allenby Capital

David Hart/Alex Brearley (Nominated Adviser)

Kelly Gardiner (Broker)

www.allenbycapital.com

Tel: +44 (0) 20 3328 5656

 

 

 

 

About Biome

Biome Technologies plc is an AIM listed, growth-orientated, commercially driven technology group. Our strategy is founded on building market-leading positions based on patented technology and serving international customers in valuable market sectors. We have chosen to do this by developing products in application areas where the value-added pricing can be justified and that are not reliant on government legislation. These products are driven by customer requirements and are compatible with existing manufacturing processes. They are market rather than technology-led.

The Group comprises two divisions, Biome Bioplastics Limited and Stanelco RF Technologies Limited. Biome Bioplastics is a leading developer of highly-functional, bio-based and biodegradable plastics. The company's mission is to produce bioplastics that challenge the dominance of oil-based polymers. Stanelco RF Technologies designs, builds and services advanced radio frequency (RF) systems. Dielectric and induction heating products are at the core of a product offering that ranges from portable sealing devices to large furnaces for the fibre optics markets.

In 2018, the Board has adopted the following three high level KPIs for the next three years to continue its ambitious momentum:

· Compound revenue growth of 25% per annum across the Group and 40% compound revenue growth in the Bioplastics division

· Diversify the Group's turnover by product and market to ensure that no one product or end customer contributes more than 15% of revenues by 2020

· Increase investment in the Group's next generation of products by spending significantly more per annum on average than the £0.3m per annum average spend over the previous strategic objective cycle

 

www.biometechnologiesplc.com

www.biomebioplastics.com and http://www.thinkbioplastic.com/ 

www.stanelcorftechnologies.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
HOLKMGMFFFGGLZM
Date   Source Headline
18th Jul 20137:00 amRNSInterim Management Statement
20th Jun 20132:34 pmRNSIssue of Equity
20th Jun 201312:45 pmRNSResult of General Meeting
17th Jun 201312:01 pmRNSHolding(s) in Company
17th Jun 201311:59 amRNSHolding(s) in Company
23rd May 20137:01 amRNSCapital Reorganisation
23rd May 20137:00 amRNSSettlement with Landlord in Respect of Leases
26th Apr 20137:00 amRNSIssue of shares to a Director Total Voting rights
25th Apr 20134:10 pmRNSResult of AGM
25th Apr 20137:00 amRNSTrading Update
4th Apr 20137:00 amRNSResearch Grant Award
3rd Apr 20134:35 pmRNSNotice of AGM and Annual Report and Accounts
28th Mar 20137:10 amRNSDirector's Remuneration and Consultancy agreement
28th Mar 20137:01 amRNSPreliminary Results
23rd Jan 20137:00 amRNSPre-close Trading Statement
2nd Nov 20127:00 amRNSTrading Update
1st Oct 20123:24 pmRNSCompletion of Sale
27th Sep 20122:03 pmRNSResult of General Meeting
7th Sep 20127:00 amRNSProposed Sale of stake in Biotec Holding GmbH
3rd Sep 20127:00 amRNSInterim Results
29th Aug 20127:00 amRNSPrototype Delivery for Stanelco RF Technologies
19th Jul 20127:00 amRNSInterim Trading Statement
17th Jul 20127:00 amRNSFinancing and Loan Repayment
12th Jul 20127:00 amRNSPatent Litigation Update
10th Jul 20124:40 pmRNSSecond Price Monitoring Extn
10th Jul 20124:35 pmRNSPrice Monitoring Extension
19th Jun 20127:00 amRNSLoan Facility Extension/Directorate Change
31st May 20127:00 amRNSTrading Update
15th May 20124:40 pmRNSSecond Price Monitoring Extn
15th May 20124:35 pmRNSPrice Monitoring Extension
25th Apr 20121:35 pmRNSResult of AGM
25th Apr 20127:00 amRNSTrading Update
4th Apr 20127:00 amRNSNotification of Award under the Public Equity Plan
29th Mar 20127:00 amRNSPreliminary Results
19th Jan 20127:00 amRNSPre-close Trading Statement
10th Jan 20127:00 amRNSContract for RF Technologies Business
16th Dec 20111:27 pmRNSDirector/PDMR Shareholding
6th Dec 20117:00 amRNSLoan Reclassification
4th Nov 20117:00 amRNSTrading Update
21st Oct 20114:35 pmRNSPrice Monitoring Extension
19th Sep 20117:00 amRNSSector Reclassification
1st Sep 20117:01 amRNSDirectorate Changes
1st Sep 20117:00 amRNSInterim Results
16th May 201111:07 amRNSDirector/PDMR Shareholding
9th May 20117:00 amRNSDirector/PDMR Shareholding
5th May 20112:28 pmRNSResult of AGM
5th May 20117:00 amRNSTrading Update
12th Apr 201112:22 pmRNSHolding(s) in Company
28th Mar 20114:23 pmRNSAnnual Report &Accounts for 2010 and Notice of AGM
24th Mar 20117:00 amRNSPreliminary Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.